Medirom Healthcare Technologies Inc (MRM)

$4.08

+0.09

(+2.24%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $3.82
    $4.08
    $4.08
    downward going graph

    6.27%

    Downside

    Day's Volatility :6.27%

    Upside

    0.0%

    downward going graph
  • $3.40
    $6.90
    $4.08
    downward going graph

    16.67%

    Downside

    52 Weeks Volatility :50.72%

    Upside

    40.87%

    downward going graph

Returns

PeriodMedirom Healthcare Technologies IncIndex (Russel 2000)
3 Months
-32.94%
0.0%
6 Months
-33.28%
0.0%
1 Year
-41.28%
0.0%
3 Years
-51.93%
-20.2%

Highlights

Market Capitalization
19.4M
Book Value
$43.19
Earnings Per Share (EPS)
0.14
PE Ratio
28.39
Profit Margin
1.69%
Operating Margin TTM
-2.27%
Return On Assets TTM
-3.6%
Return On Equity TTM
146.95%
Revenue TTM
6.8B
Revenue Per Share TTM
1398.45
Quarterly Revenue Growth YOY
-5.800000000000001%
Gross Profit TTM
1.4B
EBITDA
-139.0M
Diluted Eps TTM
0.14
Quarterly Earnings Growth YOY
0.58
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Company Financials

FY18Y/Y Change
Revenue
31.1M
-
Net Income
601.0K
-
Net Profit Margin
1.93%
-
FY19Y/Y Change
Revenue
35.9M
↑ 13.84%
Net Income
159.2K
↓ 73.86%
Net Profit Margin
0.44%
↓ 1.49%
FY20Y/Y Change
Revenue
13.7M
↓ 63.77%
Net Income
-10.5M
↓ 6328.16%
Net Profit Margin
-76.24%
↓ 76.68%
FY21Y/Y Change
Revenue
47.0M
↑ 282.02%
Net Income
-8.6M
↓ 8.24%
Net Profit Margin
-18.31%
↑ 57.93%
FY22Y/Y Change
Revenue
41.3M
↑ 0.0%
Net Income
-7.6M
↑ 0.0%
Net Profit Margin
-18.31%
↑ 0.0%
FY23Y/Y Change
Revenue
6.8B
↑ 26.21%
Net Income
115.0M
↓ 111.61%
Net Profit Margin
1.68%
↑ 19.99%
Q2 FY22Q/Q Change
Revenue
25.6M
-
Net Income
-1.5M
-
Net Profit Margin
-5.77%
-
Q3 FY22Q/Q Change
Revenue
-18.2M
↓ 10394.32%
Net Income
1.5M
↓ 14527.93%
Net Profit Margin
-8.08%
↓ 2.31%
Q2 FY23Q/Q Change
Revenue
24.0M
↓ 100.91%
Net Income
-2.6M
↓ 101.24%
Net Profit Margin
-10.95%
↓ 2.87%
Q3 FY23Q/Q Change
Revenue
24.5M
↑ 2.05%
Net Income
3.2M
↓ 222.31%
Net Profit Margin
13.12%
↑ 24.07%
FY18Y/Y Change
Total Assets
41.0M
-
Total Liabilities
42.1M
-
FY19Y/Y Change
Total Assets
43.7M
↑ 5.21%
Total Liabilities
38.2M
↓ 10.39%
FY20Y/Y Change
Total Assets
29.5M
↓ 36.07%
Total Liabilities
25.8M
↓ 35.98%
FY21Y/Y Change
Total Assets
50.0M
↑ 89.15%
Total Liabilities
51.8M
↑ 123.97%
FY22Y/Y Change
Total Assets
43.9M
↑ 0.0%
Total Liabilities
45.5M
↑ 0.0%
FY23Y/Y Change
Total Assets
6.8B
↑ 19.05%
Total Liabilities
6.6B
↑ 11.27%
Q3 FY22Q/Q Change
Total Assets
39.8M
↑ 4.8%
Total Liabilities
41.3M
↑ 1.39%
Q4 FY22Q/Q Change
Total Assets
46.2M
↑ 5.31%
Total Liabilities
49.4M
↑ 8.58%
Q1 FY23Q/Q Change
Total Assets
50.7M
↑ 11.37%
Total Liabilities
51.1M
↑ 5.15%
Q2 FY23Q/Q Change
Total Assets
42.0M
↓ 10.21%
Total Liabilities
44.8M
↓ 4.9%
Q3 FY23Q/Q Change
Total Assets
6.8B
↑ 13.05%
Total Liabilities
6.6B
↑ 2.47%
Q4 FY23Q/Q Change
Total Assets
6.8B
↑ 0.0%
Total Liabilities
6.6B
↑ 0.0%
FY18Y/Y Change
Operating Cash Flow
1.3M
-
Investing Cash Flow
-719.6K
-
Financing Cash Flow
-675.0K
-
FY19Y/Y Change
Operating Cash Flow
72.3K
↓ 94.45%
Investing Cash Flow
-348.4K
↓ 52.22%
Financing Cash Flow
3.0M
↓ 545.78%
FY20Y/Y Change
Operating Cash Flow
-3.6M
↓ 4755.91%
Investing Cash Flow
-1.4M
↑ 268.03%
Financing Cash Flow
13.9M
↑ 331.37%
FY21Y/Y Change
Operating Cash Flow
-4.8M
↑ 52.07%
Investing Cash Flow
-729.5K
↓ 39.87%
Financing Cash Flow
-3.7M
↓ 129.88%
Q2 FY21Q/Q Change
Operating Cash Flow
-1.6M
↑ 4325.24%
Investing Cash Flow
-1.8M
↑ 0.0%
Financing Cash Flow
-1.5M
↑ 127.28%
Q3 FY21Q/Q Change
Operating Cash Flow
-937.4K
↓ 40.0%
Investing Cash Flow
1.5M
↓ 179.54%
Financing Cash Flow
-456.1K
↓ 68.83%
Q4 FY21Q/Q Change
Operating Cash Flow
-908.0K
↑ 0.0%
Investing Cash Flow
1.4M
↑ 0.0%
Financing Cash Flow
-441.9K
↑ 0.0%
Q1 FY22Q/Q Change
Operating Cash Flow
-143.2M
↑ 37.05%
Investing Cash Flow
112.6M
↓ 30.96%
Financing Cash Flow
-104.4M
↑ 105.34%
Q2 FY22Q/Q Change
Operating Cash Flow
-2.3M
↓ 98.37%
Investing Cash Flow
112.6M
↑ 0.0%
Financing Cash Flow
-494.0K
↓ 99.53%

Technicals Summary

Sell

Neutral

Buy

Medirom Healthcare Technologies Inc is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Medirom Healthcare Technologies Inc
Medirom Healthcare Technologies Inc
-3.2%
-33.28%
-41.28%
-51.93%
-73.59%
Serve Robotics Inc
Serve Robotics Inc
566.48%
290.03%
290.03%
290.03%
-77.0%
Service Corporation International
Service Corporation International
3.45%
8.3%
11.44%
29.28%
58.89%
Bright Horizons Family Solutions Inc
Bright Horizons Family Solutions Inc
10.4%
17.51%
23.71%
-22.73%
-14.76%
H&r Block, Inc.
H&r Block, Inc.
4.49%
17.47%
68.0%
130.12%
104.3%
Rollins Inc.
Rollins Inc.
-5.48%
8.1%
4.31%
25.05%
104.6%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Medirom Healthcare Technologies Inc
Medirom Healthcare Technologies Inc
28.39
28.39
NA
0.0
1.47
-0.04
NA
43.19
Serve Robotics Inc
Serve Robotics Inc
152.18
NA
NA
0.0
0.0
0.0
NA
NA
Service Corporation International
Service Corporation International
21.36
21.36
1.59
3.67
0.33
0.04
0.02
10.87
Bright Horizons Family Solutions Inc
Bright Horizons Family Solutions Inc
82.02
82.02
1.76
3.14
0.07
0.03
NA
21.21
H&r Block, Inc.
H&r Block, Inc.
13.1
13.1
0.79
4.3
0.46
0.16
0.02
-0.93
Rollins Inc.
Rollins Inc.
52.51
52.51
3.54
1.01
0.36
0.15
0.01
2.55
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Medirom Healthcare Technologies Inc
Medirom Healthcare Technologies Inc
NA
$19.4M
-73.59%
28.39
1.69%
Serve Robotics Inc
Serve Robotics Inc
NA
$5.4B
-77.0%
152.18
0.0%
Service Corporation International
Service Corporation International
Buy
$10.9B
58.89%
21.36
12.73%
Bright Horizons Family Solutions Inc
Bright Horizons Family Solutions Inc
Buy
$6.8B
-14.76%
82.02
3.34%
H&r Block, Inc.
H&r Block, Inc.
Buy
$7.8B
104.3%
13.1
17.87%
Rollins Inc.
Rollins Inc.
Buy
$24.2B
104.6%
52.51
14.23%

Insights on Medirom Healthcare Technologies Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, -2.63B → 24.51M (in $), with an average increase of 5528.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -2.63M → 3.21M (in $), with an average increase of 181.8% per quarter

  • Vs HRB

    In the last 1 year, H&r Block, Inc. has given 68.0% return, outperforming this stock by 109.3%

  • Vs HRB

    In the last 3 years, H&r Block, Inc. has given 130.1% return, outperforming this stock by 182.0%

Institutional Holdings

  • Bank of America Corp

    0.01%

Company Information

Organization
Medirom Healthcare Technologies Inc
Employees
390
CEO
Mr. Kouji Eguchi
Industry
Miscellaneous

Discover More

FAQs